Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: The Vapor C Trial
VAPOR-C is a pragmatic, event-driven, randomised controlled trial, with a blinded 2x2 factorial design for
sevoflurane/propofol and for intravenous lidocaine/placebo administration.
The primary aims of this study will test if: (1) Intravenous propofol-TIVA (vs. inhalational anaesthesia), and/or (2) intravenous lidocaine analgesia (vs. placebo) improve disease-free survival (DFS) following major cancer surgery.
Peter MacCallum Cancer Centre
Parts of research done:
Literature review, Research proposal, Ethics approval